The global struggle with weight management is a well-known challenge, prompting a search for innovative and effective solutions.

A promising new study investigated the impact of a specific, powerful probiotic strain from Wecare Probiotics——Lacticaseibacillus rhamnosus LRa05, on glycemic control and gut microbiota in patients already managing Type 2 Diabetes with medication.

Ningbo, China – June 8, 2025 – WeCare Probiotics actively participated in the grand 2025 China Gut Conference, held from June 6th to 8th at the Ningbo International Convention Center.

WeCare Probiotics played a prominent role at the 20th International Probiotics and Health Symposium, held in Beijing recently. The event brought together leading experts and industry stakeholders to discuss the latest advancements in probiotics and their impact on health.

Barcelona, Spain – May 21, 2025 – Wecare Probiotics is thrilled to announce that its leading probiotic strain, Weizmannia (Bacillus) Coagulans BC99 , has been awarded the highly coveted "Ingredient of the Year: Sports Nutrition" at the distinguished NutraIngredients Awards 2025.

Wecare Probiotics was proud to co-host the "Microbial Preparations Industry Standards Symposium" recently at the Wecare Probiotics Research Institute.